Filing Details
- Accession Number:
- 0001593968-23-001469
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-29 14:29:03
- Reporting Period:
- 2023-11-28
- Accepted Time:
- 2023-11-29 14:29:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1673772 | Rapt Therapeutics Inc. | RAPT | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1400901 | William Ho | C/O Rapt Therapeutics, Inc., 561 Eccles Avenue South San Francisco CA 94080 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-11-28 | 1,500 | $13.72 | 17,520 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person on October 17, 2022.
- Includes 231 shares acquired by Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan on October 31, 2023.